SST and neoplasm: Due to the safety and efficacy of the oncolytic virus VG9/TK−, we applied this promising transgenic vector to express somatostatin fusion protein, and the therapeutic effects of both somatostatin and oncolytic virus were combined to destroy tumor tissues.